Conolidine’s analgesic effects stem from its interaction with non-opioid pain pathways. As opposed to opioids, which bind to µ-opioid receptors while in the central nervous process, conolidine modulates alternate molecular targets. A Science Developments review uncovered that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://johnb928jza6.worldblogged.com/profile